Khodov Ilya A, Belov Konstantin V, Krestyaninov Michael A, Dyshin Alexey A, Kiselev Michael G
G.A. Krestov Institute of Solution Chemistry of the Russian Academy of Sciences, Ivanovo 153045, Russia.
Materials (Basel). 2023 Feb 11;16(4):1524. doi: 10.3390/ma16041524.
The search for new forms of already known drug compounds is an urgent problem of high relevance as more potent drugs with fewer side effects are needed. The trifluoromethyl group in flufenamic acid renders its chemical structure differently from other fenamates. This modification is responsible for a large number of conformational polymorphs. Therefore, flufenamic acid is a promising structural modification of well-known drug molecules. An effective approach in this field is micronization, employing "green" supercritical fluid technologies. This research raises some key questions to be answered on how to control polymorphic forms during the micronization of drug compounds. The results presented in this work demonstrate the ability of two-dimensional nuclear Overhauser effect spectroscopy to determine conformational preferences of small molecular weight drug compounds in solutions and fluids, which can be used to predict the polymorphic form during the micronization. Quantitative analysis was carried out to identify the conformational preferences of flufenamic acid molecules in dimethyl sulfoxide-d6 medium at 25 °C and 0.1 MPa, and in mixed solvent medium containing supercritical carbon dioxide at 45 °C and 9 MPa. The data presented allows predictions of the flufenamic acid conformational preferences of poorly soluble drug compounds to obtain new micronized forms.
寻找已知药物化合物的新形式是一个具有高度相关性的紧迫问题,因为需要更有效且副作用更少的药物。氟芬那酸中的三氟甲基使其化学结构与其他芬那酸盐不同。这种修饰导致了大量的构象多晶型物。因此,氟芬那酸是对知名药物分子进行结构修饰的一个有前景的选择。该领域一种有效的方法是采用“绿色”超临界流体技术进行微粉化。这项研究提出了一些关键问题,即在药物化合物微粉化过程中如何控制多晶型形式。本工作中呈现的结果表明,二维核Overhauser效应光谱能够确定溶液和流体中小分子量药物化合物的构象偏好,这可用于预测微粉化过程中的多晶型形式。进行了定量分析,以确定氟芬那酸分子在25℃和0.1MPa的氘代二甲亚砜介质中,以及在45℃和9MPa含超临界二氧化碳的混合溶剂介质中的构象偏好。所呈现的数据有助于预测难溶性药物化合物的氟芬那酸构象偏好,以获得新的微粉化形式。